Christopher Cannon Discusses Safe Discontinuation of Anticoagulation After AFib Ablation in a New Study
Christopher Cannon, Cardiologist at Brigham and Women’s Hospital, Editor-in-Chief of Harvard Heart Letter, posted on LinkedIn:
”In patients s/p AFib ablation who maintain sinus rhythm for more than a year (with good patch monitor documentation), stopping anticoagulation appeared safe.
I (and many of my patients) have been waiting for this trial for a long time – a question that comes up so often.
If stopping, will of course need to maintain vigilance for any late recurrence – then anticoagulation will be needed.
Good discussion and comments here noting caution. It is just one study of 800 patients.
Use of ILR is a terrific way to keep immediate look for recurrences, or Apple Watch could also work.
It also makes sense to incorporate CHAD2-Vasc score in the decision, where if it is low could feel safer stopping but if high, lean more toward current practice of continuing.”
Read the full article here.
Title: Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation
Authors: Daehoon Kim, Jaemin Shim, Eue-Keun Choi, Il-Young Oh, Jun Kim, Young Soo Lee, Junbeom Park, Jum-Suk Ko, Kyoung-Min Park, Jung-Hoon Sung, Hyung Wook Park, Hyung-Seob Park, Jong-Youn Kim, Ki-Woon Kang, Dongmin Kim, Jin-Kyu Park, Dae-Hyeok Kim, Jin-Bae Kim, Hee Tae Yu, Tae-Hoon Kim, Jae-Sun Uhm, Hui-Nam Pak, Boyoung Joung
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial